Private Equity
Oculis, a Swiss developer of ophthalmic drugs, has raised $20.3 million in Series B funding. The investors included Bay City Capital, Novartis Venture Fund, Pivotal bioVenture Partners, Brunnur Ventures and Silfurberg.
4 min read · 04 January 2018
Paris and Cambridge, Massachusetts-based Enterome, a biotech company focused on treating microbiome-associated diseases with a focus on inflammatory bowel diseases and immuno-oncology indications, has secured 32 million euros in Series D funding. The investors were Seventure, Health for Life Capital, LundbeckFonden Ventures, Omnes Capital, Nestlé Health Science, Principia SGR and Bristol-Myers Squibb.
6 min read · 04 January 2018
European medical device firm Miracor Medical has raised 25 million euros in funding. The investors included Ming Capital, SFPI, SRIW and Meusinvest, Earlybird Venture Capital, Delta Partners, SHS Gesellschaft für Beteiligungsmanagement, Biomed Invest and Peppermint Venture Partners.
3 min read · 04 January 2018
2 min read · 04 January 2018
Life sciences investor Pappas Capital has named Dr. Kyle Rasbach as a partner. Previously, Rasbach was a vice president at T. Rowe Price.
2 min read · 03 January 2018
3 min read · 03 January 2018
Converge Venture Partners is seeking to raise $100 million for its maiden fund, according to an SEC filing. The Cambridge, Massachusetts-based venture firm backs tech entrepreneurs.
1 min read · 03 January 2018
DNAnexus Inc, a provider of biomedical informatics and data management, has raised $58 million in financing. Foresite Capital led the round with participation from Microsoft, GV, TPG Biotech, WuXi NextCODE, Claremont Creek Ventures and MidCap Financial.
1 min read · 03 January 2018
China-based SoYoung, an online marketplace for aesthetic medical treatments, has secured $60 million in Series D funding. Apax Digital led the round.
1 min read · 03 January 2018
San Diego and Jupiter, Florida-based Expansion Therapeutics, a developer of ribonucleic acid targeted small molecule medicines, has secured $55.3 million in Series A financing. The lead investors were 5AM Ventures, Kleiner Perkins, Novartis Venture Fund and Sanofi Ventures. Also, RA Capital Management and Alexandria Venture Investments participated in the round.
1 min read · 03 January 2018
